30-10-2026 16:10 via Drugs.com - News for Health Professionals

Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT

FRIDAY, Oct. 30, 2026 -- A 16-week course of hypofractionated postmastectomy radiation therapy (PMRT) is safe and noninferior to conventional PMRT, according to a study published online Oct. 12 in the Journal of Clinical Oncology.
Matthew M. Poppe...

Monthly News Roundup - October 2026

Patients With Psoriasis Have Increased Risks for Cataracts, Cataract Surgery

Surgical Recurrence Less Frequent With Laparoscopic Surgery for Crohn Disease

Infectious Diseases Society of America, Oct. 21-24

High-Volume Injections Not Beneficial in Midportion Achilles Tendinopathy

Childhood Measles Vaccination Rates Down Globally

American Society of Anesthesiologists, Oct. 16 to 20

Seven Predictors of Renal Dysfunction Identified in Patients With IBD

Acute Kidney Injury Up for Older Patients, Men With OD-Involved Hospitalization

ESMO: PFS, OS Extended With Divarasib in KRAS G12C-Mutated Advanced NSCLC

ESMO: Adding Abiraterone Improves Survival in De Novo Metastatic Prostate Cancer

ASN: Low Protein Intake Linked to Kidney Failure Risk in Asian Patients With CKD

Lower Serum Total Calcium Linked to Postdischarge Outcomes in HFpEF

Residential Fine Particulate Matter Linked to Minimal Residual Disease in Pediatric Leukemia

Desktop versie

Hypofractionated Postmastectomy RT Noninferior to Conventional PMRT

Pharmaceutical Industry news